Amanote Research

Amanote Research

    RegisterSign In

Cancer: A Targeted Treatment With Off-Target Risks

Nature - United Kingdom
doi 10.1038/nature21504
Full Text
Open PDF
Abstract

Available in full text

Categories
Multidisciplinary
Date

February 1, 2017

Authors
David A. FrumanSusan O'Brien
Publisher

Springer Science and Business Media LLC


Related search

DDX3, a Potential Target for Cancer Treatment

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2015English

Cripto: A Target for Breast Cancer Treatment

2003English

Antibody-Targeted Immunocarriers for Cancer Treatment

2016English

Treatment of Pancreatic Cancer With Epidermal Growth Factor Receptor-Targeted Therapy

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

HER2 Targeted Breast Cancer Therapy With Switchable Off/on Multifunctional Smart Magnetic Polymer CoreShell Nanocomposites

English

Treatment of Advanced Thyroid Cancer With Targeted Therapies: Ten Years of Experience

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2016English

The AMPK-FoxO3A Axis as a Target for Cancer Treatment

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2010English

Molecular-Targeted Nanotherapies in Cancer: Enabling Treatment Specificity

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2011English

Switching Off DNA Repair—how Colorectal Cancer Evades Targeted Therapies Through Adaptive Mutability

Signal Transduction and Targeted Therapy
Cancer ResearchGenetics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy